Tempus xT panel & PD-L1 & TUO, tissue (FFPE) + Blood **
DNA sequencing using tumor/normal match
RNA sequencing (Whole transcriptome RNA sequencing with validated fusion detection)
IHC for PD-L1 (upto 2 clones, selection from 22C3, 28-8, or SP142)
NGS Database analyse from RNA expression results for TUO (Tempus Tumor Origin)
N/A **Sent out to Ontarget Medicine Co, Ltd. (Tempus, USA).
Received specimen to reported within 4-5 weeks (Slide received to report)
Ontarget Medicine Co, Ltd. (Tempus, USA).
Referral Lab Services, Laboratory Department 14160-2